Stockscreener 앱 받기
1.42%
시간 외 거래:
Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen stock edges higher as investors weigh recent revenue growth and obesity drug opportunity - ad-hoc-news.de
Amgen stock edges higher as osteoporosis drug backbone and strong cash generation support valuation - ad-hoc-news.de
Erste Group Bank Analysts Lower Earnings Estimates for Amgen - MarketBeat
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes - GlobeNewswire Inc.
SteelPeak Wealth LLC Acquires 20,118 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock trades steady as revenue growth and pipeline updates shape investor view - ad-hoc-news.de
Assetmark Inc. Purchases 15,719 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock trades steadily as recent earnings and pipeline progress shape sentiment - Ad Hoc News
Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- G - GuruFocus
Amgen stock advances after cardiovascular data and solid Q1 2026 growth - ad-hoc-news.de
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
D.A. Davidson & CO. Trims Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp - MarketBeat
(AMGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Amgen stock holds steady as biotech pipeline and US revenue base anchor long-term story - Ad Hoc News
Amgen’s Tablet Recalls Test Its Quality Controls and Manufacturing Ambitions (AMGN) - simplywall.st
Livforsakringsbolaget Skandia Omsesidigt Purchases 10,752 Shares of Amgen Inc. $AMGN - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
AMG National Trust Bank Has $4.59 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset - MedCity News
Amgen Colo. Win May Chill States' Push To Cap Drug Prices - Law360
Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen - 24/7 Wall St.
Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling - Yahoo Finance
Amgen stock holds steady as biotech pipeline and US market presence shape the long-term story - Ad-hoc-news.de
Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC - MarketBeat
Calamos Advisors LLC Buys 3,648 Shares of Amgen Inc. $AMGN - MarketBeat
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape - Yahoo Finance Singapore
Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues - simplywall.st
Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here’s What It Means for the Stock. - TIKR.com
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Guggenheim raises Amgen stock price target to $343 on product mix - Investing.com
AMGN DCF Analysis: Intrinsic Value $292 vs Price $363 - GuruFocus
BofA raises Amgen stock price target on growth franchise execution By Investing.com - Investing.com Nigeria
BofA raises Amgen stock price target on growth franchise execution - Investing.com
J. Safra Sarasin Holding AG Sells 38,033 Shares of Amgen Inc. $AMGN - MarketBeat
Absher Wealth Management LLC Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story - ad-hoc-news.de
Castleview Partners LLC Has $2.77 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Ferguson Wellman Capital Management Inc. - MarketBeat
Cullinan Associates Inc. Has $8.98 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Fifth Third Bancorp Acquires 167,835 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as investors await the next catalyst - ad-hoc-news.de
Amgen stock steadies as the biotech group leans on scale - ad-hoc-news.de
Amgen Inc. $AMGN Shares Sold by Torray Investment Partners LLC - MarketBeat
Candriam S.C.A. Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Conning Inc. Has $33.85 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as biotech pipeline and U.S. market listing shape long-term investor expect - ad-hoc-news.de
Amgen's Biotech Crossroads: Congressional Divergence Amid Patent Cliffs and Pipeline Promise - Kavout | AI
ETFs Investing in Amgen Inc. Stocks - TradingView
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr - ad-hoc-news.de
Amgen stock reflects biotech heavyweight's steady role in US healthcare - ad-hoc-news.de
Munich Reinsurance Co Stock Corp in Munich Sells 2,916 Shares of Amgen Inc. $AMGN - MarketBeat
Ibex Wealth Advisors Increases Stake in Amgen Inc. $AMGN - MarketBeat
First Horizon Corp Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Regeneron Cites Medtronic Ruling In Amgen Bundling Case - Law360
How AI Is Changing Drug Discovery and What It Will Take to Unlock Its Full Potential - Amgen
Truist Raises its Price Target on Amgen (AMGN) - Insider Monkey
Amgen (AMGN): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Amgen stock responds to obesity drug progress and solid pipeline momentum - AD HOC NEWS
Sumitomo Mitsui Trust Group Inc. Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Greenwood Capital Associates LLC Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen highlights its biotech pipeline as a driver for long-term growth - Ad-hoc-news.de
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $370 - Moomoo
Amgen highlights oncology pipeline progress as a major biotech on Nasdaq - Ad-hoc-news.de
2.25%
0.67%
자본화:
|
볼륨(24시간):